{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:34:41Z","timestamp":1792028081448,"version":"4.4.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T00:00:00Z","timestamp":1299456000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>The optimal means for detecting and managing liver transplantation (LT) patients with latent tuberculosis (TB) are not well defined. Our study aims were to (1) determine the frequency and risk factors of latent TB in a large cohort of consecutive adult LT candidates and (2) determine the safety and efficacy of isoniazid treatment in LT recipients with latent TB. A review of patients assessed for latent TB by skin testing using purified protein derivative (PPD; January 2004 to September 2008) or with the interferon-\u03b3 release assay QuantiFERON-TB Gold (QFT; March 2008 to October 2009) was undertaken. The baseline clinical features and outcomes of subjects with latent TB and subjects without latent TB were compared. Twenty-five of 420 subjects (6.0%) were positive for PPD. In comparison, 11 of 119 subjects (9.2%) had a positive QFT assay, and 15 others (13%) had indeterminate results. Both PPD-positive and QFT-positive subjects were less likely to be Caucasian than subjects without latent TB (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). The 3-year survival rate of the 25 LT recipients with latent TB was similar to that of the 296 LT recipients without latent TB (78.7% versus 74.6%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.58). Fifteen of the 25 latent TB patients received isoniazid at a mean of 0.67 months after LT. Although isoniazid was discontinued in 8 subjects because of possible side effects, none of the 25 latent TB patients developed TB reactivation after transplantation with a mean follow-up of 33 months. In conclusion, both QFT testing and PPD testing demonstrate similar rates of detecting latent TB infection in American LT candidates, but QFT testing also leads to a moderate rate of indeterminate test results. Early isoniazid chemoprophylaxis after LT is poorly tolerated and is frequently discontinued. Liver Transpl, 2011. \u00a9 2011 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.22203","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T09:56:17Z","timestamp":1299578177000},"page":"306-314","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":57,"title":["Detection and management of latent tuberculosis in liver transplant patients"],"prefix":"10.1097","volume":"17","author":[{"given":"Syed-Mohammed","family":"Jafri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit G.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert John","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20250124","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project.","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"R3-11-20250124","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/00007890-200211270-00006","article-title":"Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area.","volume":"74","author":"Benito","year":"2002","journal-title":"Transplantation"},{"key":"R4-11-20250124","doi-asserted-by":"crossref","first-page":"174","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection: an update.","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"R5-11-20250124","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infectionUnited States, 2010.","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R6-11-20250124","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"R7-11-20250124","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2007.02011.x","article-title":"Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection to liver transplantation.","volume":"7","author":"Manuel","year":"2007","journal-title":"Am J Transplant"},{"key":"R8-11-20250124","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/CDLI.6.6.934-937.1999","article-title":"Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis.","volume":"6","author":"Johnson","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"R9-11-20250124","first-page":"1311","article-title":"Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay.","volume":"12","author":"Goletti","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"R10-11-20250124","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/644754","article-title":"Prospective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting.","volume":"30","author":"Cummings","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R11-11-20250124","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.humimm.2008.10.005","article-title":"Diagnosis of latent tuberculosis infection in patients awaiting liver transplantation.","volume":"70","author":"Lindemann","year":"2009","journal-title":"Hum Immunol"},{"key":"R12-11-20250124","first-page":"879","article-title":"Identification and management of latent tuberculosis infection.","volume":"79","author":"Hauck","year":"2009","journal-title":"Am Fam Physician"},{"key":"R13-11-20250124","first-page":"19","article-title":"Recommendations of the Advisory Council for the Elimination of Tuberculosis.","volume":"44","year":"1995","journal-title":"MMWR Recomm Rep"},{"key":"R14-11-20250124","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.transproceed.2006.02.012","article-title":"Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of Quantiferon TB Gold results in the transplant setting: a case report.","volume":"38","author":"Codeluppi","year":"2006","journal-title":"Transplant Proc"},{"key":"R15-11-20250124","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1378\/chest.114.5.1244","article-title":"The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis.","volume":"114","author":"Rao","year":"1998","journal-title":"Chest"},{"key":"R16-11-20250124","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management.","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R17-11-20250124","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MAJ.0b013e31812f5a4e","article-title":"Clinical features and outcome of tuberculosis in solid organ transplant recipients.","volume":"334","author":"Hsu","year":"2007","journal-title":"Am J Med Sci"},{"key":"R18-11-20250124","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/lt.21709","article-title":"Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data.","volume":"15","author":"Holty","year":"2009","journal-title":"Liver Transpl"},{"key":"R19-11-20250124","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1034\/j.1399-0012.2002.01098.x","article-title":"Mycobacterium tuberculosis infection and laboratory diagnosis in solid-organ transplant recipients.","volume":"16","author":"Cavusoglu","year":"2002","journal-title":"Clin Transplant"},{"key":"R20-11-20250124","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1164\/rccm.200701-057OC","article-title":"Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey.","volume":"177","author":"Bennett","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R21-11-20250124","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/hep.23007","article-title":"Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit.","volume":"50","author":"Lucey","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R22-11-20250124","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00040007","article-title":"Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients.","volume":"30","author":"Kobashi","year":"2007","journal-title":"Eur Respir J"},{"key":"R23-11-20250124","first-page":"286","article-title":"Use of t-SPOT.TB in latent tuberculosis infection diagnosis in general and immunosuppressed populations.","volume":"30","author":"Piana","year":"2007","journal-title":"New Microbiol"},{"key":"R24-11-20250124","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","article-title":"The tuberculin skin test.","volume":"17","author":"Huebner","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R25-11-20250124","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1001\/jama.293.22.2746","article-title":"Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing.","volume":"293","author":"Pai","year":"2005","journal-title":"JAMA"},{"key":"R26-11-20250124","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","article-title":"Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection.","volume":"172","author":"Ferrara","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-11-20250124","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/597351","article-title":"Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals.","volume":"48","author":"Aichelburg","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R28-11-20250124","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/j.1600-6143.2005.01087.x","article-title":"Management of tuberculosis in the transplant recipient.","volume":"5","author":"Rubin","year":"2005","journal-title":"Am J Transplant"},{"key":"R29-11-20250124","first-page":"1054","article-title":"Importance of surveillance mycobacterial cultures after liver transplantation.","volume":"60","author":"Torre-Cisneros","year":"1995","journal-title":"Transplantation"},{"key":"R30-11-20250124","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2165\/00002018-199615060-00004","article-title":"Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status.","volume":"15","author":"Durand","year":"1996","journal-title":"Drug Saf"},{"key":"R32-11-20250124","first-page":"1","article-title":"Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.","volume":"54","author":"Taylor","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"R33-11-20250124","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0962-8479(92)90092-X","article-title":"Liver transplantation: an unheralded probable risk for tuberculosis.","volume":"73","author":"Salizzoni","year":"1992","journal-title":"Tuber Lung Dis"},{"key":"R34-11-20250124","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/01.tp.0000266578.45634.4f","article-title":"Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.","volume":"83","author":"Jahng","year":"2007","journal-title":"Transplantation"},{"key":"R35-11-20250124","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00007890-200209270-00029","article-title":"Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.","volume":"74","author":"Singh","year":"2002","journal-title":"Transplantation"},{"key":"R36-11-20250124","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/arrd.1973.107.4.523","article-title":"Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis.","volume":"107","author":"Bailey","year":"1973","journal-title":"Am Rev Respir Dis"},{"key":"R37-11-20250124","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.1979.03290380015017","article-title":"Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients.","volume":"241","author":"Byrd","year":"1979","journal-title":"JAMA"},{"key":"R38-11-20250124","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","article-title":"Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.","volume":"281","author":"Nolan","year":"1999","journal-title":"JAMA"},{"key":"R39-11-20250124","first-page":"991","article-title":"Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.","volume":"117","author":"Kopanoff","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"R40-11-20250124","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"key":"R41-11-20250124","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug-induced liver injury in the United States.","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl"},{"key":"R42-11-20250124","first-page":"364","article-title":"Isoniazid hepatotoxicity after orthotopic liver transplantation.","volume":"63","author":"Schluger","year":"1996","journal-title":"Mt Sinai J Med"},{"key":"RU43-11-20250124","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/520159","article-title":"Risk of tuberculosis in tuberculin skin test-positive liver transplant patients.","volume":"29","author":"Chaparro","year":"1999","journal-title":"Clin Infect Dis"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.22203","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.22203","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201103000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T17:07:33Z","timestamp":1737738453000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201103000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.22203","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}